Showing results (61-70 of 117) with videos related to

Sort By:
Pageof 12
Anticancer Research|August 5, 2006
Vitamin D metabolism in human prostate cells: implications for prostate cancer chemoprevention by vitamin DJohn N Flanagan, Michael V Young, Kelly S Persons, et al.
Physiological and Biochemical Zoology : PBZ|April 16, 2003
Do panther chameleons bask to regulate endogenous vitamin D3 production?Gary W Ferguson, William H Gehrmann, Kristopher B Karsten, et al.
Pediatrics|May 5, 2010
Low 25-hydroxyvitamin D levels in adolescents: race, season, adiposity, physical activity, and fitnessYanbin Dong, Norman Pollock, Inger Susanne Stallmann-Jorgensen, et al.
The Journal of Clinical Endocrinology and Metabolism|November 8, 2007
Serum 25-hydroxyvitamin D and bone mineral density in a racially and ethnically diverse group of menMarian T Hannan, Heather J Litman, Andre B Araujo, et al.
The FEBS Journal|August 25, 2010
Three-step hydroxylation of vitamin D3 by a genetically engineered CYP105A1: enzymes and catalysisKeiko Hayashi, Kaori Yasuda, Hiroshi Sugimoto, et al.
Journal of Molecular Endocrinology|June 23, 2011
Mechanism of the anti-proliferative action of 25-hydroxy-19-nor-vitamin D(3) in human prostate cellsEiji Munetsuna, Sachie Nakabayashi, Rie Kawanami, et al.
Steroids|September 6, 2011
19-Nor-2α-(3-hydroxypropyl)-1α,25-dihydroxyvitamin D3 (MART-10) is a potent cell growth regulator with enhanced chemotherapeutic potency in liver cancer cellsKun-Chun Chiang, Chun-Nan Yeh, Huang-Yang Chen, et al.
The Journal of Steroid Biochemistry and Molecular Biology|September 30, 2014
Synthesis and metabolic studies of 1α,2α,25-, 1α,4α,25- and 1α,4β,25-trihydroxyvitamin D3Masashi Takano, Daisuke Sawada, Kaori Yasuda, et al.
Journal of Cellular Biochemistry|February 19, 2014
Potent antiproliferative effects of 25-hydroxy-16-ene-23-yne-vitamin D₃ that resists the catalytic activity of both CYP27B1 and CYP24A1Steve Y Rhieu, Andrew J Annalora, Erika LaPorta, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 9, 2004
Inhibition of proliferation and induction of apoptosis by 25-hydroxyvitamin D3-3beta-(2)-Bromoacetate, a nontoxic and vitamin D receptor-alkylating analog of 25-hydroxyvitamin D3 in prostate cancer cellsNarasimha Swamy, Tai C Chen, Sara Peleg, et al.
Pageof 12